Cigna’s Evernorth Drops Prior Authorization for TMS, Boosting BrainsWay’s Access
Event summary
- Cigna’s Evernorth Behavioral Health will eliminate prior authorization requirements for TMS coverage starting March 6, 2026.
- The policy change affects over 18 million covered lives across 12 states.
- BrainsWay’s Deep TMS systems are widely adopted in the U.S. for MDD and OCD treatment.
- Evernorth covers TMS for both adolescents and adults with major depressive disorder (MDD) and obsessive-compulsive disorder (OCD).
The big picture
Cigna’s Evernorth Behavioral Health’s decision to eliminate prior authorization for TMS coverage marks a significant shift in mental health reimbursement policies. This move aligns with broader industry trends toward reducing administrative barriers to care, potentially accelerating adoption of advanced neurostimulation therapies like BrainsWay’s Deep TMS. The policy change could set a precedent for other insurers, reshaping the competitive landscape for mental health treatments.
What we're watching
- Adoption Pace
- How quickly other insurers follow Evernorth’s lead in eliminating prior authorization for TMS.
- Revenue Impact
- Whether BrainsWay can convert expanded access into meaningful revenue growth.
- Competitive Dynamics
- The pace at which competitors in the neurostimulation space respond to this policy shift.
Related topics